Gene expression analysis underscores the multifaceted role of GPR17 activation in the modulation of vital genes in several pathways, such as MAPK/ERK, PI3K–Akt, STAT, and NF-kB, controlling GBM disease progression. Here, NFKB1 is linked to glioblastoma.